Dates, quotes, doses, and source links stay attached to every displayed amount. A dose without a published price stays “Not published”.
Plan pricing is not dose-attributable Dose-level price check. The provider publishes multiple plan or commitment prices, but the public evidence does not attribute them to doses.
Evidence current as of 2026-08-24 · dose-pricing source The provider publishes multiple plan, commitment, introductory, or renewal prices, but no exact dose-price pairs identify one amount for this dose.
mg/week published price 0.25 mg/week Not published 0.5 mg/week Not published 1 mg/week Not published 1.7 mg/week Not published 2.4 mg/week Not published Plan pricing is not dose-attributable Dose-level price check. The provider publishes multiple plan or commitment prices, but the public evidence does not attribute them to doses.
Evidence current as of 2026-08-24 · dose-pricing source The provider publishes multiple plan, commitment, introductory, or renewal prices, but no exact dose-price pairs identify one amount for this dose.
mg/week published price 2.5 mg/week Not published 5 mg/week Not published 7.5 mg/week Not published 10 mg/week Not published 12.5 mg/week Not published 15 mg/week Not published At a glance Unknown is kept separate from a verified negative.
Medication paths
Compounded semaglutide and tirzepatide injections after licensed provider review
Insurance
Insurance billing is not published on the captured page.
Consultation or membership
An online medical evaluation is required; no separate consultation fee is published.
View consultation or membership source · current as of 2026-08-16Shipping or timing
The captured page does not publish an exact shipping window.
View shipping or timing source · current as of 2026-08-16Cancellation
Cancel anytime is advertised.
View cancellation source · current as of 2026-08-16State evidence
The Katalys program terms identify the United States; a complete state-by-state availability list is not published.
View state evidence source (partner portal — not publicly viewable) · current as of 2026-08-16Editorial tradeoffs Useful for comparing: People comparing compounded GLP-1 bundle prices across one- to twelve-month commitments
Limitations in the record The lowest monthly prices require longer commitments No exact shipping window is published Compounded drugs are not FDA approved Feature evidence and unknowns The captured page does not publish an exact shipping window.
Compounded GLP-1 medications are prepared by licensed U.S. pharmacies; no 503A or 503B designation is published.
No Clinic Scout patient reviews are published for this provider. Submissions go through manual moderation before anything appears here.
Methodology and evidence boundary Provider identity comes from the governed registry. Prices come from the dated provider pricing matrix. Program facts come from the content ledger. Clinic Scout does not infer availability, medical fit, ratings, or review counts.
Affiliate and ranking methodology 